Revenue
2020
2021
2022
2023
2024
2025
Prime Medicine, Inc. (PRME)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $4.6M | $3.0M | $0 | $0 | $0 | $5.2M |
| Research & development | $160.6M | $155.3M | $147.9M | $86.7M | $70.5M | $3.0M |
| Operating expenses | $213.0M | $205.4M | $204.8M | $116.5M | $84.5M | $6.1M |
| Operating income | −$208.3M | −$202.5M | −$204.8M | −$116.5M | −$84.5M | −$932,000 |
| EBITDAderived | −$201.0M | −$196.3M | −$200.1M | −$114.3M | −$83.9M | −$889,000 |
| Net income | −$201.1M | −$195.9M | −$198.1M | −$121.8M | −$165.4M | −$3.4M |
| Basic EPSper diluted share | -$1.35 | -$1.65 | -$2.18 | -$4.19 | -$14.19 | -$1.91 |
| Diluted EPSper diluted share | -$1.35 | -$1.65 | -$2.18 | -$4.19 | -$14.19 | -$1.91 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 1, 2025Form 4 | Alphabet Inc. +3TenPercentOwner | BuyCommon Stock · indirect | 1.50M | $3.30 | $4.95M | 3.26M |
| Aug 1, 2025Form 4 | NELSEN ROBERTDirector,TenPercentOwner | BuyCommon Stock · indirect | 3.03M | $3.30 | $10.00M | 6.23M |
| Aug 1, 2025Form 4 | ARCH Venture Fund XII, L.P. +2TenPercentOwner | BuyCommon Stock · indirect | 3.03M | $3.30 | $10.00M | 6.23M |
| Aug 1, 2025Form 4 | GILLIS STEVEN +7TenPercentOwner | BuyCommon Stock · indirect | 3.03M | $3.30 | $10.00M | 6.23M |
| Jun 30, 2025Form 4 · 10b5-1 | Liu David R.TenPercentOwner | BuyCommon Stock | 21.0K | $2.52 | $52.9K | 20.24M |